ORMIOR PHARMACEUTICALS PTY LTD – Trademark Portfolio
Entity Type: 82
ORMIOR PHARMACEUTICALS PTY LTD holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 8 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 5 trademarks are registered and 2 are pending. Notable registered marks include ZMILE, ISPARK, MIMIFA, and MAYLIKE. The owner is based in SYDNEY.
SUITE 3, LEVEL 7 1 O'CONNELL STREET
SYDNEY , AU
Showing of trademarks Trademarks
Trademark Classifications
ORMIOR PHARMACEUTICALS PTY LTD's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does ORMIOR PHARMACEUTICALS PTY LTD have?
ORMIOR PHARMACEUTICALS PTY LTD has 10 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 pending, 3 abandoned.
What trademark classes does ORMIOR PHARMACEUTICALS PTY LTD file in?
ORMIOR PHARMACEUTICALS PTY LTD files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are ORMIOR PHARMACEUTICALS PTY LTD's most well-known trademarks?
ORMIOR PHARMACEUTICALS PTY LTD's registered trademark portfolio includes well-known marks such as ZMILE, ISPARK, MIMIFA, and MAYLIKE. These are among 5 currently registered trademarks in the portfolio.
What is ORMIOR PHARMACEUTICALS PTY LTD's trademark registration success rate?
ORMIOR PHARMACEUTICALS PTY LTD has a 63% trademark registration rate, with 5 out of 8 resolved applications resulting in successful registration. Currently, 2 applications are pending review.